Imexhs
Imexhs provides medical imaging software solutions, including RIS PACS, to healthcare facilities. Their cloud-based platform leverages AI to optimize radiology workflows for clinics, hospitals, and radiology centers. They aim to improve efficiency and accuracy in medical imaging processes.
Short position
Imexhs (ASX:IME) has 0.00% of its shares on issue reported as short positions as of 5 Oct 2026, or about 1 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.33% in March 2020. IME is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Imexhs (IME) financials
Results, ratios and statements
Latest result
Year to 31 Dec 2025 (FY25) vs FY24, figures in AUD, the reporting currency
- Revenue
- $29.0Mvs $26.4M (FY24)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- −$2.9Mvs −$2.6M (FY24)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- −$0.056vs −$0.058 (FY24)
- Yahoo Finance, as at 29 Sep 2026
- Rev YoY
- +9.5%FY
- EPS YoY
- n/aTTM
Key ratios
Year to 31 Dec 2025 (FY); balance sheet at 31 Dec 2025; prices to 9 Oct 2026
- Gross margin
- 100.0%
- Operating margin
- −3.1%
- Net margin
- −9.9%
- FCF margin
- −2.3%
- ROE
- −19.0%
- ROA
- −12.7%
- FCF conversion
- n/a
- Net cash (excl. leases)
- $2.8M
- Net debt / EBITDA
- −2.1×
- Current ratio
- 1.7×
- Interest cover
- −2.4×
- Cash dividends paid / net profit
- n/a
- Market cap
- $16.2M
- P/E
- n/a
- P/B
- 1.0×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Revenue | $29.0M | $26.4M | $19.7M | $17.1M |
| Gross profit | $29.0M | $26.4M | $19.7M | $17.1M |
| Operating income | −$897.2K | −$2.2M | −$2.6M | −$2.5M |
| EBITDA | −$452.6K | $45.6K | −$1.3M | −$748.9K |
| EBIT | −$2.7M | −$2.1M | −$3.7M | −$2.5M |
| Interest expense | $368.8K | $462.2K | $328.0K | $438.0K |
| Pretax income | −$3.0M | −$2.6M | −$4.0M | −$2.9M |
| Tax | −$156.6K | $57.6K | $172.7K | $92.4K |
| NPAT | −$2.9M | −$2.6M | −$4.2M | −$3.0M |
| Net interest income | −$350.9K | −$436.9K | −$298.6K | −$396.0K |
| EPS basic | −$0.056 | −$0.058 | −$0.10 | −$0.085 |
| EPS diluted | −$0.056 | −$0.058 | −$0.10 | −$0.085 |
| Shares | 54.1M | 45.9M | 42.6M | 41.3M |
Financial reports
The company's own filings, newest first
- Half Yearly Report and AccountsHalf Year Results28 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Jul 2026via asx_announcements
- FY26 Q1 Quarterly Activities Report and Appendix 4CQuarterly Report30 Apr 2026via asx_announcements
- Appendix 4E & Annual Report 2025Annual Results27 Feb 2026via asx_announcements
- 2025 Q4 Quarterly Activities Report & Appendix 4CQuarterly Report30 Jan 2026via asx_announcements
- 2025 Q3 Quarterly Activities Report & Appendix 4CQuarterly Report31 Oct 2025via asx_announcements
- Half Yearly Report and AccountsHalf Year Results29 Aug 2025via asx_announcements
- 2025 Q2 Quarterly Activities Report and Appendix 4CQuarterly Report31 Jul 2025via asx_announcements
- 2025 Q1 Quarterly Activities Report & Appendix 4CQuarterly Report30 Apr 2025via asx_announcements
- Annual Report to shareholdersAnnual Report31 Mar 2025via asx_announcements
Showing 10 of 19 reports